Factors | Group | Number of studies | Pooled crude mortality (95%CI) | I2 (%) | p value |
---|---|---|---|---|---|
Bloodstream infection | Yes | 15 | 0.45 (0.39–0.51) | 41 | 0.002 |
No | 5 | 0.21 (0.08–0.33) | 40 | Ref | |
Clade | Clade I | 11 | 0.39 (0.31–0.47) | 49 | 0.343 |
Non- Clade I | 4 | 0.31 (0.14–0.48) | 83 | Ref | |
FLC resistance | Higher | 10 | 0.29 (0.21–0.38) | 60 | 0.415 |
Lower | 3 | 0.49 (0.29–0.70) | 70 | Ref | |
AmB resistance | Higher | 6 | 0.29 (0.19–0.40) | 45 | 0.159 |
Lower | 6 | 0.43 (0.32–0.53) | 62 | Ref | |
Continent | Asia | 9 | 0.44 (0.38–0.51) | 0 | 0.000 |
America | 5 | 0.43 (0.27–0.59) | 78 | 0.164 | |
Africa | 2 | 0.37 (0.21–0.53) | 81 | 0.303 | |
Europe | 3 | 0.20 (0.04–037) | 66 | Ref | |
Publication Year | 2018–2019 | 11 | 0.42 (0.31–0.53) | 86 | 0.769 |
2016–2017 | 5 | 0.39 (0.30–0.48) | 0 | 0.415 | |
2013–2015 | 3 | 0.47 (0.31–0.63) | 0 | Ref |